Wealth Enhancement Advisory Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wealth Enhancement Advisory Services, LLC

$65.4 Billion
Q4 2025

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 22,363 shares of REGN stock, worth $15.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

22,363

Previous 17,585 27.17%

Holding current value

$15.5 Million

Previous $9.89 Million 56.85%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 08, 2026	BUY	$557.73 - $694.99 $2.66 Million - $3.32 Million	4,778 Added 27.17%	22,363 $15.5 Million
Q3 2025 Oct 29, 2025	BUY	$534.91 - $598.71 $4.24 Million - $4.74 Million	7,923 Added 82.0%	17,585 $9.89 Million
Q2 2025 Jul 10, 2025	SELL	$483.07 - $625.6 $11.6 Million - $15.1 Million	-24,083 Reduced 71.37%	9,662 $5.07 Million
Q1 2025 Apr 16, 2025	SELL	$634.14 - $744.83 $7.77 Million - $9.12 Million	-12,246 Reduced 26.63%	33,745 $21.4 Million
Q4 2024 Mar 17, 2025	BUY	$701.85 - $1046.91 $10.6 Million - $15.8 Million	15,077 Added 48.77%	45,991 $32.8 Million

Q4 2024 Jan 10, 2025	SELL	$701.85 - $1046.91 $56,148 - $83,752	-80 Reduced 0.26%	30,914 $22 Million
Q3 2024 Oct 23, 2024	BUY	$1024.09 - $1201.76 $7.54 Million - $8.84 Million	7,360 Added 31.14%	30,994 $32.6 Million
Q2 2024 Jul 16, 2024	BUY	$883.2 - $1071.19 $426,585 - $517,384	483 Added 2.09%	23,634 $24.8 Million
Q1 2024 Apr 15, 2024	BUY	$902.69 - $993.35 $2.18 Million - $2.4 Million	2,412 Added 11.63%	23,151 $22.3 Million
Q4 2023 Jan 30, 2024	BUY	$775.18 - $881.7 $2.03 Million - $2.31 Million	2,620 Added 14.46%	20,739 $18.2 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $9.17 Million - $11.2 Million	13,248 Added 271.98%	18,119 $14.9 Million
Q2 2023 Jul 21, 2023	BUY	$700.03 - $830.35 $341,614 - $405,210	488 Added 11.13%	4,871 $3.5 Million
Q1 2023 Apr 25, 2023	BUY	$680.49 - $826.97 $159,915 - $194,337	235 Added 5.67%	4,383 $3.6 Million
Q4 2022 Feb 01, 2023	BUY	$705.89 - $766.39 $2.93 Million - $3.18 Million	4,148 New	4,148 $2.99 Million
Q3 2019 Nov 06, 2019	SELL	$273.46 - $318.39 $1.41 Million - $1.65 Million	-5,173 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$299.6 - $414.82 $792,442 - $1.1 Million	2,645 Added 104.63%	5,173 $1.58 Million
Q1 2019 Apr 30, 2019	BUY	$372.08 - $439.57 $940,618 - $1.11 Million	2,528 New	2,528 $870,000

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

86.4M

Call Options Held

2.38M

Put Options Held

1.61M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History